Ardent Health, Inc. (ARDT) Earnings Call Transcripts

15 earnings calls from August 2024 to August 5, 2026

NYSE US Health Care Health Care Providers and Services

Ardent Health, Inc.'s Latest Earnings Call - June 10, 2026

In the second quarter of fiscal year 2026, Ardent Health, Inc. reported a revenue of $1.2 billion, which was in line with expectations, while reaffirming its guidance for the year despite observed volume softness across its portfolio. The company is focusing on operational improvements and margin expansion, with management highlighting an increase in their impact program savings target from $45 million to $55 million. The transition to a new CEO is seen as a proactive move to enhance operational execution amid industry challenges, signaling a strategic shift towards outpatient care and disciplined M&A activity.

Reported metrics

MetricValueContext
Revenue $1.2B (inline) inline with expectations
Impact Program Savings Target $55M (positive) raised from $45M
CapEx as % of Revenue over 3% (positive) increased from historically under 3%
M&A Capacity $1B (neutral) available for acquisitions
Denial Activity stabilized (positive) improvement noted after challenges
Urgent Care Locations 46 (positive) increased from previous years

Guidance from management

Management reaffirmed their guidance for fiscal year 2026, indicating confidence in achieving their targets despite current volume softness.

What management said

Well, I think it's -- yes, no, good question, and I think it's -- I'll say at a personal level, the easiest answer, and that is, Dave has proven himself inside of the organization over the past 15 months and executed at a level that has accelerated and enhanced our operational position. And in terms of really demonstrating that this was a proactive move and not a reactive move. I think that's probably no further evid...
— Alfred Lumsdaine, June 10, 2026 earnings call
Sure. Absolutely. Yes, I have really had the pleasure working with Dave for 15 months. I tell people who I met and ask about Dave, he is an extraordinary leader from the standpoint of creating. He is 1 of the most authentic, consistent and accountable driven leaders that I've worked with in my career. And I think, yes, if I were to highlight 3 strengths, it would be just those things. And I think those are the dime...
— Alfred Lumsdaine, June 10, 2026 earnings call

What analysts pressed on

Analysts expressed concerns regarding the volume softness impacting revenue growth and the potential challenges posed by increased denial rates. There was also inquiry into how the new CEO would navigate these industry headwinds.

Main topics on the call

Read the full Ardent Health, Inc. transcript (June 10, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Ardent Health, Inc.

Ardent Health, Inc. (ARDT) is a publicly listed company in the Health Care Providers and Services industry, within the Health Care sector. It trades on NYSE and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 15 calls on record spanning August 15, 2024 to August 5, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 15 Ardent Health, Inc. earnings call transcripts on record, spanning August 15, 2024 to August 5, 2026. Based on this history, Ardent Health, Inc. reports quarterly. The most recent call on file is dated August 5, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
ARDT
Exchange
NYSE
Country
US
Sector
Health Care
Industry
Health Care Providers and Services
Calls on record
15
First call
August 15, 2024
Most recent
August 5, 2026
Reporting cadence
quarterly
Quarter Date
Q2 FY2026 Aug 5, 2026 Read transcript
Company Conference Presentations Jun 10, 2026 Read transcript
Company Conference Presentations May 13, 2026 Read transcript
Q1 FY2026 May 6, 2026 Read transcript
Q4 FY2025 Mar 5, 2026 Read transcript
Q3 FY2025 Nov 13, 2025 Read transcript
Company Conference Presentations Sep 8, 2025 Read transcript
Q2 FY2025 Aug 6, 2025 Read transcript
Company Conference Presentations May 14, 2025 Read transcript
Q1 FY2025 May 7, 2025 Read transcript
Q4 FY2024 Feb 27, 2025 Read transcript
Company Conference Presentations Jan 14, 2025 Read transcript
Q3 FY2024 Nov 7, 2024 Read transcript
Company Conference Presentations Sep 5, 2024 Read transcript
Q2 FY2024 Aug 15, 2024 Read transcript